Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-11-02 Sale | 2021-11-04 9:34 pm | F-star Therapeutics Inc. | FSTX | Kayitalire Louis Chief Medical Officer | 64 | $6.8256 | $437 | 54,255 (Direct) | View |
2021-10-04 Sale | 2021-10-06 4:38 pm | F-star Therapeutics Inc. | FSTX | Kayitalire Louis Chief Medical Officer | 64 | $7.2256 | $462 | 54,319 (Direct) | View |
2021-07-02 Sale | 2021-07-07 9:13 pm | F-star Therapeutics Inc. | FSTX | Kayitalire Louis Chief Medical Officer | 1,054 | $8.43 | $8,885 | 54,383 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-07-29 Exercise | 2023-01-09 4:04 pm | N/A 2029-12-18 | F-star Therapeutics Inc. | FSTX | Race Geoffrey Director | 3,937 | $0 | 7,874 (Direct) | View |
2022-07-29 Exercise | 2023-01-09 4:04 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Race Geoffrey Director | 3,937 | $0.11 | 7,874 (Direct) | View |
2022-07-29 Exercise | 2022-08-02 9:08 pm | N/A 2028-10-01 | F-star Therapeutics Inc. | FSTX | Forster Eliot President and CEO | 260,977 | $0 | 421,537 (Direct) | View |
2022-07-29 Exercise | 2022-08-02 9:08 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Forster Eliot President and CEO | 260,977 | $0.11 | 421,537 (Direct) | View |
2022-07-29 Exercise | 2022-08-02 9:07 pm | N/A 2029-05-07 | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 76,619 | $0 | 114,463 (Direct) | View |
2022-07-29 Exercise | 2022-08-02 9:07 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 76,619 | $0.11 | 114,463 (Direct) | View |
2022-06-17 Option Award | 2022-06-22 5:15 pm | N/A 2032-06-17 | F-star Therapeutics Inc. | FSTX | Brady Todd C Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-17 Option Award | 2022-06-22 5:14 pm | N/A 2032-06-17 | F-star Therapeutics Inc. | FSTX | Race Geoffrey Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-17 Option Award | 2022-06-22 5:13 pm | N/A 2032-06-17 | F-star Therapeutics Inc. | FSTX | Benz Edward JR Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-17 Option Award | 2022-06-22 5:12 pm | N/A 2032-06-17 | F-star Therapeutics Inc. | FSTX | Klein Pamela M. Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-17 Option Award | 2022-06-22 5:11 pm | N/A 2032-06-17 | F-star Therapeutics Inc. | FSTX | Bermingham Nessan Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-17 Option Award | 2022-06-22 5:06 pm | N/A 2032-06-17 | F-star Therapeutics Inc. | FSTX | Arkowitz David Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-03-31 Option Award | 2022-04-04 4:07 pm | N/A 2032-03-31 | F-star Therapeutics Inc. | FSTX | Forster Eliot President and CEO | 126,909 | $0 | 126,909 (Direct) | View |
2022-03-31 Option Award | 2022-04-04 4:06 pm | N/A 2032-03-31 | F-star Therapeutics Inc. | FSTX | DEPTULA-HICKS DARLENE M Treasurer and CFO | 24,902 | $0 | 24,902 (Direct) | View |
2022-03-31 Option Award | 2022-04-04 4:03 pm | N/A 2032-03-31 | F-star Therapeutics Inc. | FSTX | Kayitalire Louis Chief Medical Officer | 35,719 | $0 | 35,719 (Direct) | View |
2022-03-31 Option Award | 2022-04-04 4:02 pm | N/A 2032-03-31 | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 132,469 | $0 | 132,469 (Direct) | View |
2022-01-09 Option Award | 2022-01-11 5:32 pm | N/A 2032-01-09 | F-star Therapeutics Inc. | FSTX | Kayitalire Louis Chief Medical Officer | 53,634 | $0 | 53,634 (Direct) | View |
2022-01-09 Option Award | 2022-01-11 5:31 pm | N/A 2032-01-09 | F-star Therapeutics Inc. | FSTX | DEPTULA-HICKS DARLENE M Treasurer and CFO | 59,823 | $0 | 59,823 (Direct) | View |
2022-01-09 Option Award | 2022-01-11 5:30 pm | N/A 2032-01-09 | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 74,263 | $0 | 74,263 (Direct) | View |
2022-01-09 Option Award | 2022-01-11 5:27 pm | N/A 2032-01-09 | F-star Therapeutics Inc. | FSTX | Forster Eliot President and CEO | 165,028 | $0 | 165,028 (Direct) | View |
2020-11-20(A) Option Award | 2021-08-24 6:34 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Bermingham Nessan Director | 16,875 | $0 | 16,875 (Direct) | View |
2020-11-20(A) Option Award | 2021-08-24 6:30 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | DEPTULA-HICKS DARLENE M Treasurer and CFO | 26,437 | $0 | 26,437 (Direct) | View |
2020-11-20(A) Option Award | 2021-08-24 6:25 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Kayitalire Louis Chief Medical Officer | 26,437 | $0 | 26,437 (Direct) | View |
2021-06-04 Option Award | 2021-06-07 4:18 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Krol Patrick Johan Hendrik Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-06-04 Option Award | 2021-06-07 4:16 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Klein Pamela M. Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-06-04 Option Award | 2021-06-07 4:14 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Brady Todd C Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-06-04 Option Award | 2021-06-07 4:12 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Bermingham Nessan Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-06-04 Option Award | 2021-06-07 4:09 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Race Geoffrey Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-06-04 Option Award | 2021-06-07 4:06 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Benz Edward JR Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-06-04 Option Award | 2021-06-07 4:03 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Arkowitz David Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-03-09 Option Award | 2021-03-11 4:16 pm | N/A 2031-03-09 | F-star Therapeutics Inc. | FSTX | Forster Eliot President and CEO | 127,924 | $0 | 388,901 (Direct) | View |
2021-03-09 Option Award | 2021-03-11 4:11 pm | N/A 2021-03-09 | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 22,561 | $0 | 99,180 (Direct) | View |
2021-03-09 Option Award | 2021-03-11 4:06 pm | N/A 2031-03-09 | F-star Therapeutics Inc. | FSTX | DEPTULA-HICKS DARLENE M Treasurer and CFO | 25,894 | $0 | 54,320 (Direct) | View |
2021-03-09 Option Award | 2021-03-11 4:03 pm | N/A 2031-03-09 | F-star Therapeutics Inc. | FSTX | Kayitalire Louis Chief Medical Officer | 12,880 | $0 | 40,169 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 4:29 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Brewis Neil Chief Scientific Officer | 18,000 | $0 | 37,844 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 4:26 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Forster Eliot President and CEO | 142,000 | $0 | 160,560 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 4:22 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Kayitalire Louis Chief Medical Officer | 29,000 | $0 | 55,437 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 4:17 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Bermingham Nessan Director | 87,000 | $0 | 103,875 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 4:10 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | Benz Edward JR Director | 4,385 | $0 | 4,385 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 4:06 pm | N/A N/A | F-star Therapeutics Inc. | FSTX | DEPTULA-HICKS DARLENE M Treasurer and CFO | 30,000 | $0 | 56,437 (Direct) | View |